STERIS plc (Ireland) ($STE) Stock Forecast: Down 0.4% Today

What is STERIS plc (Ireland)?

Steris (STE) is a global leader in infection prevention, decontamination, and surgical and critical care technologies, with a focus on healthcare, pharmaceutical, and medical device customers.

Why is STERIS plc (Ireland) going down?

STE stock is down 0.4% on Aug 7, 2024 14:41

• Despite surpassing expectations in earnings and revenue for the first quarter of fiscal 2025, Steris (STE) witnessed a significant downward trend in the market.
• The company's impressive financial results and revenue growth, especially in the healthcare sector, could not counteract the negative impact on its stock.
• The bearish movement in STE stock might have been influenced by shareholders' support for board and auditor proposals, which could have been overshadowed by external market conditions or other unrelated concerns.
• The decline in Steris (STE) stock value could be a result of investors' reactions to external elements or uncertainties ahead, despite the company's robust financial performance.

STE Price Chart

STE News

Steris ( STE ) Beats Q1 Earnings and Revenue Estimates

Steris (STE) delivered earnings and revenue surprises of 1% and 1.47%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2317427/steris-ste-beats-q1-earnings-and-revenue-estimates

STERIS Plc Q1 Profit Increases, Beats Estimates

WASHINGTON (dpa-AFX) - STERIS plc (STE) released earnings for its first quarter that increased from the same period last year and beat the Street estimates.The company''s earnings came in at $145.4…

https://www.finanznachrichten.de/nachrichten-2024-08/62927899-steris-plc-q1-profit-increases-beats-estimates-020.htm

STERIS Announces Financial Results for Fiscal 2025 First Quarter

DUBLIN, IRELAND , Aug. 06, 2024 ( GLOBE NEWSWIRE ) -- STERIS plc ( NYSE: STE ) ( "STERIS" or the "Company" ) today announced financial results for its fiscal 2025 first quarter ended June 30, 2024. Total revenue from continuing operations for the first quarter of fiscal 2025 increased 8% to $1.3 ...

https://www.globenewswire.com/news-release/2024/08/06/2925527/0/en/STERIS-Announces-Financial-Results-for-Fiscal-2025-First-Quarter.html

STERIS Announces Financial Results for Fiscal 2025 First Quarter | STE Stock News

STERIS reports strong Q1 FY2025: Revenue up 8% to $1.3B, adjusted EPS rises to $2.03. Healthcare segment shines with 10% growth. Company reaffirms optimistic full-year outlook despite challenges in Life Sciences.

https://www.stocktitan.net/news/STE/steris-announces-financial-results-for-fiscal-2025-first-gdm0dalu1kxv.html

STERIS plc shareholders approve board and auditor proposals

https://www.investing.com/news/company-news/steris-plc-shareholders-approve-board-and-auditor-proposals-93CH-3550517

https://www.investing.com/news/company-news/steris-plc-shareholders-approve-board-and-auditor-proposals-93CH-3550517

Trending Today

Jupiter ($JUP) Crypto Forecast: Up 5.2% Today

Novo Nordisk A/S ($NVO) Stock Forecast: Down 5.1% Today

Lennar Corporation Class A ($LEN) Stock Forecast: Down 5.2% Today

Bittensor ($TAO) Crypto Forecast: Up 9.4% Today

Aptos ($APT) Crypto Forecast: Up 6.6% Today

Sui ($SUI) Crypto Forecast: Up 11.4% Today

Intel Corporation ($INTC) Stock Forecast: Up 5.6% Today

Bumble Inc. ($BMBL) Stock Forecast: Down 5.4% Today

Fetch.ai ($FET) Crypto Forecast: Up 5.1% Today

FedEx Corporation ($FDX) Stock Forecast: Down 14.5% Today

STERIS plc (Ireland) Price History

09.04.2024 - STE Stock was up 5.1%

• The company reported a loss of $1.4 million in its fiscal Q4 earnings, which was lower than expectations.
• Despite the loss, Steris managed to match Q4 earnings estimates, with a slight revenue surprise.
• The downgrade of Steris from a "buy" rating to a "hold" rating might have initially caused some uncertainty in the market.
• Investors might have reacted positively to the company's ability to meet earnings estimates and the potential for future growth beyond just revenue and EPS, leading to the bullish movement in the stock price.

08.10.2023 - STE Stock was down 6.2%

• Steris PLC reported Q2 revenues that surpassed estimates, indicating continued momentum in the healthcare business. However, margins were down, which may have contributed to the bearish movement.
• Despite beating Q2 top and bottom line estimates, Steris PLC reaffirmed its FY23 outlook, which could have disappointed investors and led to the bearish market movement.
• The earnings summary shows a significant improvement in earnings compared to the same period last year, but the negative EPS in the previous year may have influenced the bearish sentiment.
• The slight beat in estimated earnings and revenue growth may not have met investors' high expectations, resulting in the bearish movement.

09.04.2024 - STE Stock was up 6.9%

• The company reported a loss in its fiscal Q4 earnings, aligning with earnings estimates.
• Despite the reported loss, the stock displayed a bullish movement, suggesting investor focus may be on other positive aspects of the company.
• The company was downgraded from a "buy" rating to a "hold" rating by an analyst platform, which typically impacts the stock negatively. However, the market movement remained bullish.
• Investor optimism regarding Steris' competitive strengths and financial metrics could be contributing to the bullish movement despite the mixed earnings report.

31.06.2023 - STE Stock was down 1.6%

• The bearish movement in STE's stock today can be attributed to the news of Nisa Investment Advisors LLC increasing its stake in the company. Despite the positive sentiment shown by Nisa Investment Advisors LLC, the market may have interpreted this as a potential overvaluation of the stock, leading to a sell-off. Additionally, the announcement of a dividend hike may have raised concerns about the company's financial health and sustainability of future dividends, further contributing to the bearish movement.

11.04.2023 - STE Stock was up 11.1%

• STE had a strong bullish movement today.
• STE beat Q4 earnings and revenue estimates, which led to a positive market sentiment towards the stock.
• The company's Q1 profit increased from last year and beat Street estimates, indicating a positive outlook for the company.
• STE's Non-GAAP EPS of $2.30 beats by $0.15, and revenue of $1.38B beats by $110M, which further strengthens the positive sentiment towards the stock.

08.01.2024 - STE Stock was down 5.0%

• Despite STERIS (STE) reporting strong Q3 earnings and beating estimates, the stock experienced a bearish movement.
• The market may have reacted negatively to the fact that the earnings beat was only marginal, with a 2.30% surprise on earnings and a 4.22% surprise on revenues.
• Investors might have been expecting a more significant beat, leading to disappointment and selling pressure on the stock.
• It's possible that the market was also influenced by other factors not mentioned in the provided articles, such as broader market trends or investor sentiment towards the healthcare sector.

26.05.2023 - STE Stock was up 0.5%

• Today, STE had a strong bullish movement. This could be due to the following reasons:
• STE announced the acquisition of surgical instrumentation assets from Becton, Dickinson and Company in a $540 million transaction. This could be seen as a positive move for the company, as it expands their product lineup and could lead to increased revenue.
• Voya Investment Management LLC raised its position in STE shares during the fourth quarter, which could have increased investor confidence in the company.
• STE has been growing and deleveraging its balance sheet since the Cantel deal in 2021, which could be seen as a positive sign for investors.
• The sale of the surgical instrumentation platform by Becton, Dickinson and Company to STE could have been seen as a positive move for both companies, leading to increased investor confidence in STE.

09.06.2024 - STE Stock was down 2.5%

• The current downward trend in STE stock may stem from investor wariness of broader economic challenges.
• Although the AST segment shows strong recovery potential, general economic uncertainties could be outweighing positive outlook.
• Investors appear to be adopting a cautious stance, analyzing the interplay between STE's business strengths and external economic conditions.

07.07.2024 - STE Stock was down 0.4%

• Despite surpassing expectations in earnings and revenue for the first quarter of fiscal 2025, Steris (STE) witnessed a significant downward trend in the market.
• The company's impressive financial results and revenue growth, especially in the healthcare sector, could not counteract the negative impact on its stock.
• The bearish movement in STE stock might have been influenced by shareholders' support for board and auditor proposals, which could have been overshadowed by external market conditions or other unrelated concerns.
• The decline in Steris (STE) stock value could be a result of investors' reactions to external elements or uncertainties ahead, despite the company's robust financial performance.